Mitrade Insights is dedicated to providing investors with rich, timely and most valuable financial information to help investors grasp the market situation and find timely trading opportunities.

2021

Best News & Analysis Provider

FxDailyInfo

2022

Best Forex Educational Resources Global

International Business Magazine

Insights

News

Neurocrine Biosciences: A Smart Biotech Bet With Blockbuster Potential

Source Motley_fool

Explore the exciting world of Neurocrine Biosciences (NASDAQ: NBIX) with our expert analysts in this Motley Fool Scoreboard episode. Check out the video below to gain valuable insights into market trends and potential investment opportunities!
*Stock prices used were the prices of Feb. 19, 2025. The video was published on March 26, 2025.

Should you invest $1,000 in Neurocrine Biosciences right now?

Before you buy stock in Neurocrine Biosciences, consider this:

Where to invest $1,000 right now? Our analyst team just revealed what they believe are the 10 best stocks to buy right now. Learn More »

The Motley Fool Stock Advisor analyst team just identified what they believe are the 10 best stocks for investors to buy now… and Neurocrine Biosciences wasn’t one of them. The 10 stocks that made the cut could produce monster returns in the coming years.

Consider when Nvidia made this list on April 15, 2005... if you invested $1,000 at the time of our recommendation, you’d have $739,720!*

Stock Advisor provides investors with an easy-to-follow blueprint for success, including guidance on building a portfolio, regular updates from analysts, and two new stock picks each month. The Stock Advisor service has more than quadrupled the return of S&P 500 since 2002*. Don’t miss out on the latest top 10 list, available when you join Stock Advisor.

See the 10 stocks »

*Stock Advisor returns as of March 24, 2025

Karl Thiel has no position in any of the stocks mentioned. Keith Speights has no position in any of the stocks mentioned. The Motley Fool recommends Neurocrine Biosciences. The Motley Fool has a disclosure policy.

Disclaimer: For information purposes only. Past performance is not indicative of future results.

Recommended Articles

Here’s Why The BNB Price Could Rally To $12,000 Before Ethereum The BNB price is sitting below the spotlight that has surrounded Bitcoin, Ethereum, and Solana in recent months, but a new technical outlook suggests that this quiet phase may be exactly where the

Author NewsBTC

20 hours ago

The BNB price is sitting below the spotlight that has surrounded Bitcoin, Ethereum, and Solana in recent months, but a new technical outlook suggests that this quiet phase may be exactly where the

Solana Market Structure Warns Of More Downside Despite Oversold Conditions Solana’s price action continues to flash caution signals, even as momentum indicators suggest oversold conditions. The broader market structure remains tilted to the downside, with bearish waves

Author NewsBTC

20 hours ago

Solana’s price action continues to flash caution signals, even as momentum indicators suggest oversold conditions. The broader market structure remains tilted to the downside, with bearish waves

Ethereum Withdrawals From Exchanges Just Hit An 8-Month Low: Find Out What Investors Are Waiting For Ethereum is holding above $2,300 as the market builds toward what feels like a decisive move in either direction. The price is constructive but unresolved, and an Arab Chain report has just surfaced

Author NewsBTC

20 hours ago

Ethereum is holding above $2,300 as the market builds toward what feels like a decisive move in either direction. The price is constructive but unresolved, and an Arab Chain report has just surfaced

Dogecoin’s XRP Fractal Just Put A Date On The Next ATH Run: Analyst Dogecoin may not be finished with its multi-year compression phase if a new XRP fractal chart from analyst Charting Guy continues to track. The setup suggests DOGE’s next decisive run toward a

Author NewsBTC

20 hours ago

Dogecoin may not be finished with its multi-year compression phase if a new XRP fractal chart from analyst Charting Guy continues to track. The setup suggests DOGE’s next decisive run toward a

AMD rose about 5% after beating first-quarter revenue and adjusted earnings estimates Advanced Micro Devices (AMD) rose about 5% in late trading Tuesday after the chip company beat Wall Street’s first-quarter targets and gave a stronger sales forecast for the next quarter. AMD reported $10.25 billion in quarterly revenue, above the $9.89 billion expected by LSEG. Adjusted earnings came in at $1.37 per share, beating the $1.29...

Author Cryptopolitan

20 hours ago

Advanced Micro Devices (AMD) rose about 5% in late trading Tuesday after the chip company beat Wall Street’s first-quarter targets and gave a stronger sales forecast for the next quarter. AMD reported $10.25 billion in quarterly revenue, above the $9.89 billion expected by LSEG. Adjusted earnings came in at $1.37 per share, beating the $1.29...

Popular Symbols